Gerresheimer AG GXI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €28.64
- Day Range
- €27.68–27.68
- 52-Week Range
- €15.52–—
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 34.54M
- Market Cap
- €956.07M
- Volume/Avg
- — / 166,889
Key Statistics
- Price/Earnings (Normalized)
- 9.46
- Price/Sales
- 0.43
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 13,528
- Website
- https://www.gerresheimer.com
Valuation
|
Metric
|
GXI
|
|---|---|
Price/Earnings (Normalized) | 9.46 |
Price/Book Value | 0.91 |
Price/Sales | 0.43 |
Price/Cash Flow | 5.28 |
Price/Earnings
GXI
Financial Strength
|
Metric
|
GXI
|
|---|---|
Quick Ratio | 0.45 |
Current Ratio | 0.81 |
Interest Coverage | −2.41 |
Quick Ratio
GXI
Profitability
|
Metric
|
GXI
|
|---|---|
Return on Assets (Normalized) | −0.00% |
Return on Equity (Normalized) | −0.00% |
Return on Invested Capital (Normalized) | 2.66% |
Return on Assets
GXI
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|x@Vrd#% | LOCK|@&% | $138B | |||
| Becton Dickinson & Co
BDX
| LOCK|YR | LOCK|gLSD | $48B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|R#Xj<C | LOCK|P!JS^ | $31B | |||
| ResMed Inc
RMD
| LOCK|sN?cqWzS | LOCK|$!^$ | $31B | |||
| Alcon Inc
ALC
| LOCK|>tTMVjx | LOCK|<$Ww | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|VT%^$>x | LOCK|c@ | $26B | |||
| Solventum Corp
SOLV
| LOCK|Q!xlGd | LOCK|@S^ | $15B | |||
| Baxter International Inc
BAX
| LOCK|!f | LOCK|Mrvd | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|Lwrn?> | LOCK|X%sR | $11B | |||
| Repligen Corp
RGEN
| LOCK|kl&!^%&H | LOCK|L^hVC | $10B |
United States